REAL-WORLD TREATMENT PATTERNS IN THE METASTATIC HORMONE-SENSITIVE PROSTATE CANCER SETTING ACROSS EUROPE

被引：0
|
作者：
Castro, E. [1 ]
Orji, C. [2 ]
Ribbands, A. [3 ]
Butcher, J. [3 ]
Walley, M. [4 ]
Li, W. [5 ]
Ghate, S. [2 ]
机构：
[1] Hosp Univ 12 Octubre, Madrid, Spain
[2] Merck & Co Inc, Rahway, NJ USA
[3] Adelphi Real World, Bollington, Cheshire, England
[4] Adelphi Real World, Macclesfield, Che, England
[5] AstraZeneca Pharmaceut LP, Gaithersburg, MD USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HSD62
引用
收藏
页码：S231 / S232
页数：2
相关论文
共 50 条
  • [1] Real-world treatment of metastatic hormone-sensitive prostate cancer in the USA, Europe and Asia
    Goebell, Peter J.
    Raina, Rutika
    Chen, Stephanie
    Rege, Sanika
    Shah, Ruchit
    Grossman, Jamie Partridge
    Waldeck, A. Reginald
    FUTURE ONCOLOGY, 2024, 20 (14) : 903 - 918
  • [2] HOMOLOGOUS RECOMBINATION REPAIR TESTING PATTERNS AND BARRIERS IN METASTATIC HORMONE-SENSITIVE AND METASTATIC CASTRATION-RESISTANT PROSTATE CANCER ACROSS EUROPE: A REAL-WORLD SURVEY
    Castro, E.
    Orji, C.
    Ribbands, A.
    Butcher, J.
    Walley, M.
    Li, W.
    Ghate, S.
    VALUE IN HEALTH, 2024, 27 (06) : S222 - S222
  • [3] Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer: An Analysis of Real-World Practice Patterns from the CancerLinQ Database
    Eule, Corbin J.
    Kuna, Elizabeth Molina
    Robin, Tyler P.
    Gershman, Boris
    Flaig, Thomas W.
    Kim, Simon P.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (12) : 447e17 - 447e24
  • [4] Real-world utilisation of upfront chemohormonal therapy in metastatic hormone-sensitive prostate cancer
    Kelly, R.
    Wong, S. S. L.
    Shapiro, J.
    Weickhardt, A. J.
    Parente, P.
    Azad, A.
    Uccellini, A.
    Torres, J.
    Parnis, F.
    Kwan, E.
    Brown, S.
    Steer, C.
    Warren, M.
    Gibbs, P.
    Anton, A.
    Tran, B.
    ANNALS OF ONCOLOGY, 2022, 33 : S1498 - S1499
  • [5] Real-world treatment patterns in metastatic hormone-sensitive prostate cancer (mHSPC) patients in the US, Germany, France, China and Japan
    Goebell, P. J.
    Shah, R.
    Raina, R.
    Rege, S.
    Chen, S. L.
    Lee, V. E.
    Waldeck, R.
    ANNALS OF ONCOLOGY, 2021, 32 : S660 - S661
  • [6] Real-World Treatment Patterns and Survival Outcomes in Metastatic Hormone-Sensitive Prostate Cancer: Insights From a Retrospective Cohort Study
    Tashkandi, Emad
    CANCER MANAGEMENT AND RESEARCH, 2025, 17 : 419 - 428
  • [7] LACK OF CONCORDANCE BETWEEN REAL-WORLD TREATMENT PATTERNS AND CLINICAL GUIDELINE RECOMMENDATIONS FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) PATIENTS
    Goebell, P. J.
    Shah, R.
    Raina, R.
    Rege, S.
    Chen, S.
    Partridge, J.
    Waldeck, R.
    VALUE IN HEALTH, 2022, 25 (07) : S497 - S497
  • [8] A real-world comparison of docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancer
    Tsaur, Igor
    Heidegger, Isabel
    Bektic, Jasmin
    Kafka, Mona
    van den Bergh, Roderick C. N.
    Hunting, Jarmo C. B.
    Thomas, Anita
    Brandt, Maximilian P.
    Hoefner, Thomas
    Debedde, Eliott
    Thibault, Constance
    Ermacora, Paola
    Zattoni, Fabio
    Foti, Silvia
    Kretschmer, Alexander
    Ploussard, Guillaume
    Rodler, Severin
    von Amsberg, Gunhild
    Tilki, Derya
    Surcel, Christian
    Rosenzweig, Barak
    Gadot, Moran
    Gandaglia, Giorgio
    Dotzauer, Robert
    CANCER MEDICINE, 2021, 10 (18): : 6354 - 6364
  • [9] Treatment of metastatic hormone-sensitive prostate cancer
    Rane, Jayant K.
    Chowdhury, Amani
    Kinnaird, William
    Marks, Gillian
    Davda, Reena
    TRENDS IN UROLOGY & MENS HEALTH, 2021, 12 (06) : 7 - 10
  • [10] Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter Study
    Kafka, Mona
    Giannini, Giulia
    Artamonova, Nastasiia
    Neuwirt, Hannes
    Ofner, Heidemarie
    Kramer, Gero
    Bauernhofer, Thomas
    Luger, Ferdinand
    Hoefner, Thomas
    Loidl, Wolfgang
    Griessner, Hubert
    Lusuardi, Lukas
    Bergmaier, Antonia
    Berger, Andreas
    Winder, Thomas
    Weiss, Sarah
    Bauinger, Severin
    Krause, Steffen
    Drerup, Martin
    Heinrich, Elmar
    Schneider, Magdalena
    Madersbacher, Stephan
    Vallet, Sonia
    Stoiber, Franz
    Laimer, Sarah
    Hruby, Stephan
    Schachtner, Gert
    Nagele, Udo
    Lenart, Sebastian
    Ponholzer, Anton
    Pfuner, Jacob
    Wiesinger, Clemens
    Kamhuber, Christoph
    Muelduer, Ecan
    Bektic, Jasmin
    Horninger, Wolfgang
    Heidegger, Isabel
    CLINICAL GENITOURINARY CANCER, 2024, 22 (02) : 458 - 466.e1
12345